David Shaw’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
David Shaw's EDIT Position: Q3 2026 in Review
David Shaw increased its Editas Medicine (EDIT) stake by 68% in Q3 2026, buying an estimated $3.78M and bringing the position to 3,190,146 shares worth $8.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1991.
David Shaw first reported a position in EDIT in Q4 2016 and has held it in 40 quarters since. The position peaked at $98.8M in Q4 2020. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- David Shaw held 3,190,146 shares of Editas Medicine worth $8.2M as of Q3 2026.
- David Shaw bought 1,289,144 Editas Medicine shares in Q3 2026, an estimated $3.78M.
- Editas Medicine made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #1991 holding.
- David Shaw first reported a position in Editas Medicine in Q4 2016 and has held it in 40 quarters since.
- David Shaw's Editas Medicine position peaked at $98.8M in Q4 2020.
- 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.